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ABSTRACT 
Objective: The main purpose of this study is to prepare a floating micro articulated drug delivery system of ciprofloxacin by using non-aqueous 
solvent evaporation technique to increase the bioavailability and therapeutic effectiveness of the drug by prolonging its gastric residence time.  
Methods: Floating microparticles were prepared by using different low-density polymers such as ethyl cellulose and hydroxypropyl methylcellulose either 
alone or in combination with the aid of non-aqueous solvent evaporation technique. All the formulated microparticles were subjected to various evaluation 
parameters such as percentage yield, drug content, drug entrapment, rheological studies, floating characteristics and in vitro drug release studies.  
Results: Drug-excipient compatibility studies performed with the help of FTIR instrument indicated that there were no interactions. Results 
revealed that non-aqueous solvent evaporation technique is a suitable technique for the preparation of floating microspheres as most of the 
formulations were discrete and spherical in shape with a good yield of 65% to 85% and 15 to 22 h of floating duration with 90% of maximum 
percentage floating capacity shown by formulation FM9. Though, different drug-polymer ratios, as well as a combination of polymers, play a 
significant role in the variation of overall characteristics of formulations. Based on the data of various evaluation parameters such as particle size 
analysis, drug content, drug entrapment, rheological studies and in vitro drug release characteristics formulation FM9 was found to fulfil the criteria 
of ideal floating drug delivery system.  
Conclusion: Floating microparticles were successfully prepared, and from this study, it can be concluded that the developed floating microspheres 
of ciprofloxacin can be used for prolonged drug release in the stomach to improve the bioavailability and patient compliance.  
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INTRODUCTION 
Oral controlled release (CR) dosage forms (DFs) have been developed 
for the past 3 decades due to their considerable therapeutic 
advantages. However, this approach has not been suitable for a variety 
of important drugs, characterised by a narrow absorption window in 
the upper part of the gastrointestinal tract i.e. stomach and small 
intestine. This is due to the relatively short transit time of the DF in 
these anatomical segments. Thus, after only a short period of less than 
6 h, the CR-DF has already left the upper gastrointestinal tract, and the 
drug is released in non-absorbing distal segments of the 
gastrointestinal tract. This results in a short absorption phase that is 
often accompanied by lesser bioavailability. The medications that are 
included in the category of narrow absorption window drugs are 
mostly associated with improved absorption at the jejunum and ileum 
due to their enhanced absorption properties e. g. large surface area, in 
comparison to the colon; or because of the enhanced solubility of the 
drug in the stomach as opposed to more distal parts of the 
gastrointestinal tract. It was suggested that compounding narrow 
absorption window drugs in a unique pharmaceutical DF with gastro 
retentive properties would enable an extended absorption phase of 
these drugs. After oral administration, such a DF would be retained in 
the stomach and release the drug there in a controlled and prolonged 
manner, so that the drug could be supplied continuously to its 
absorption sites in the upper gastrointestinal tract. This mode of 
administration would best achieve the known pharmacokinetic and 
pharmacodynamics advantages of CR-DFs for these drugs. The need 
for gastro-retentive dosage forms (GRDFs) has led to extensive efforts 
in both academia and industry towards the development of such drug 
delivery systems. These efforts resulted in GRDFs that were designed 
in large part [1].  
Over the past three decades, the pursuit and exploration of devices 
designed to be retained in the upper part of the gastrointestinal (GI) 
tract has advanced consistently in terms of technology and diversity, 
encompassing a variety of systems and devices such as floating 
systems, raft systems, expanding systems, swelling systems, 
bioadhesive systems and low-density systems. Gastric retention will 
provide advantages such as the delivery of drugs with narrow 
absorption windows in the small intestinal region. Also, longer 
residence time in the stomach could be advantageous for local action 
in the upper part of the small intestine, for example, treatment of 
peptic ulcer disease. Furthermore, improved bioavailability is 
expected for drugs that are absorbed readily upon release in the GI 
tract. In the present study, the floating micro particles of 
ciprofloxacin as GRDFs were prepared using polymers such as ethyl 
cellulose and HPMC K4M at different proportions using individual 
polymer or in a combination of both polymers with the help of non-
aqueous solvent evaporation technique [2].  
MATERIALS AND METHODS 
Ciprofloxacin was obtained as a gift sample from Zydus Cadila, 
Baghekhola, E. Sikkim. Polymers such as hydroxypropyl 
methylcellulose (HPMC) K4M was obtained from Loba-Chem. Pvt. Ltd., 
Mumbai. Ethyl cellulose was provided by Thomas Baker Pvt. Ltd., 
Mumbai. All other reagents and chemicals were of analytical grade. 
Drug-polymer compatibility study through FTIR 
Before the preparation of microspheres, compatibility of the drug 
with polymers present in microspheres was performed. The Fourier 
transform infrared radiation measurement (FTIR) spectral 
measurements were taken at ambient temperature using IR 
spectrophotometer (Shimadzu, model 840, Japan). In this method 
peak of the pure drug was matched with that of drug and polymer in 
the range of 4000-400 cm-1 for 100 scans [3]. 
Preparation of microspheres by non-aqueous solvent 
evaporation method 
Microspheres containing antibiotic drug ciprofloxacin were prepared 
by a non-aqueous solvent evaporation method. Briefly, drug and ethyl 
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cellulose were mixed in acetone at various ratios. The slurry was 
slowly introduced into 30 ml of liquid paraffin while being stirred at 
1200 rpm by a mechanical stirrer equipped with a three-bladed 
propeller at room temperature. The solution was stirred for 4hr to 
allow the solvent to evaporate completely and the microspheres were 
collected by filtration. The microspheres were repeatedly washed with 
petroleum ether (40 °-60 °C) until free from oil. The collected 
microspheres were dried for 1 h at room temperature and 
subsequently stored in desiccators over fused Calcium chloride [4]. 
Compositions of different formulations are given in table 1, 2 and 3. 
 
Table 1: Formulation composition of microspheres prepared by using ethyl cellulose 
S. No. Ingredients  Quantity 
FM1 FM2 FM3 FM4 
1 Ciprofloxacin (mg) 100 100 100 100 
2 Ethyl Cellulose(mg) 100 200 300 400 
3 Acetone(ml) 12 12 12 12 
 
Table 2: Formulation composition of microspheres prepared by using HPMC 
S. No. Ingredients  Quantity 
FM5 FM6 FM7 FM8 
1 Ciprofloxacin (mg) 100 100 100 100 
2 HPMC(mg) 100 200 300 400 
3 Acetone(ml) 12 12 12 12 
 
Table 3: Formulation composition of microspheres prepared by using combination of ethyl cellulose and HPMC 
S. No. Ingredients  Quantity 
 FM9 FM10 FM11 FM12 
1 Ciprofloxacin (mg) 100 100 100 200 
2 Ethyl cellulose (mg) 100 100 200 100 
3 HPMC (mg) 100 200 100 100 
4 Acetone (ml) 12 12 12 12 
FM = Formulation Microsphere, HPMC = Hydroxypropyl methylcellulose 
 
Evaluation of prepared floating microspheres 
Determination of yield of microspheres  
Determination of % yield of microspheres 
Thoroughly dried microspheres were collected and weighed 
accurately. The percentage yield was then calculated using formulae 
given below [5].  
Percentage Yield =
Weight of obtained microspheres
Total weight of drug and polymer
x100 
Determination of particle size of microspheres  
The particle size of prepared microspheres from each batch was 
determined by the optical microscopy method using an ocular 
micrometre which was previously calibrated with stage 
micrometre [5]. 
Measurement of floating capacity  
An in vitro floating study was carried out using 0.1(N) HCL as a 
dispersing medium. Microspheres were spread over the surface of 
400 ml of dispersing medium at 37±0.5 °C. A paddle rotating at 100 
rpm agitated the medium. Each fraction of microspheres floating on 
the surface and those settled down were collected at a 
predetermined time point. The collected samples were weighed 
after drying [6].  
Percentage of floating of microspheres  
=  
weight of floating microspheres
Initial weight of  microspheres
 × 100 
Determination of drug content in microspheres  
Drug-loaded microspheres (100 mg) were powdered and suspended 
in 100 ml 0.1 (N) HCL solutions and kept for 24 h. It was stirred for 5 
min and filtered. Ciprofloxacin content in the filtrate was 
determined spectrophotometrically at 278 nm using a regression 
derived from the standard curve [5].  
Determination of drug entrapment in microspheres  
The drug entrapment efficiency was calculated by the equation [5]. 
Entrapment Efficiency =  
Practical Drug Content
Theoritical drug content
 × 100 
The entire test was performed in triplicate. 
Rheological properties 
The angle of repose, Carr’s index, Bulk density, True density, 
Porosity, and Hausner’s ratio were determined to assess the 
flowability of the prepared microspheres. 
Angle of repose  
The angle of repose was determined by using funnel method; the 
accurately weighed spheres were taken in the funnel. The height of funnel 
was adjusted in such as way that the tip of funnel just touches the apex of 
the heap of blends. The blends were allowed to flow through funnel freely 
onto the surface. The diameter of powder cone was measured; angle of 
repose was calculated by using following equation [7].  
Tanθ =  
h
r
  
Where the; h–height of pile, θ–angle of repose, r–radius of base pile 
and <25-excellent flow, 25–30-good flow, 30–40-passable,>40-very 
poor flow. 
Bulk density  
Apparent bulk density (ρb) was measured by pouring the pre-weight 
(M) blend into a graduated cylinder. The bulk volume (Vb) of the 
blend was determined. Then the bulk density was calculated by 
using the formula [7-9]. 
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ρb	  	
M
Vb
 
Tapped density 
The measuring cylinder containing a known mass (M) of the blend 
was tapped for a fixed time, and the minimum volume (Vt) occupied 
in the cylinder was measured. The tapped density (ρt) was 
calculated by using the following formula [7-9]. 
ρt	  	
M
Vt
 
True density  
True density is defined as the ratio of the weight of powder and the 
tapped volume of powder. It was determined by placing a graduated 
cylinder, containing a known mass of microspheres. The cylinder was 
allowed to fall under its own weight onto a hard surface from the 
height of 10 cm at a 2-second interval. The tapping was continued until 
no further change in volume was noted [8-10].  
True	density	% ρp& 	 	
Mass	of	microspheres	
Volume	of	microspheres	after	tapping	%Vp&	
	 100 
Consolidation index %  
It is one of a method for determining flow properties and also called 
as Carrs’s index of compressibility. It is indirectly related to the 
relative flow rate, cohesiveness and particle size. It is a simple, fast 
and popular method of predicting powder flow characteristics [8, 9].  
Percentage	Consolidation	index	
 	
Tapped	density ' Bulk	density
Tapped	density
	 100 
In Carr’s index, the value below 15% indicates a powder with 
usually give rise to good flow characteristics, whereas above 25% 
indicates poor flowability. Lower Hausner’s ratio (<1.25) indicates 
better flow properties than higher ones (>1.25) 
Hausner’s ratio  
Hausner’s	ratio  	
Tapped	Density
Bulk	Density	
	 100 
Lower Hausner’s ratio (<1.25) indicates better flow properties than 
higher ones (>1.25) [8, 9].  
Loose surface crystals study  
Ciprofloxacin loaded microspheres were evaluated for loose 
surface crystal study to observe the excess drug present on the 
surface of microspheres. From each batch, 100 mg microsphere 
formulation was accurately weighed and transferred carefully to 
the 100 ml of double distilled water. After vigorous shaking for 5 
min, the system was subjected to filtration through Whatman filter 
paper 41. The amount of drug lost infiltrate was determined 
spectrophotometrically and calculated as a percentage of total 
drug content [11]. 
Determination of swelling properties 
The dynamic swelling property of microspheres in the dissolution 
medium was determined. Microspheres of known weight were 
placed in dissolution solution for 3hr and the swollen microspheres 
were collected by a centrifuge and the wet weight of the swollen 
microspheres was determined by first blotting the particles with 
filter paper to remove absorbed water on the surface and then 
weighed immediately on an electronic balance [12]. The percentage 
of swelling of microspheres in the dissolution media was then 
calculated by using following equation- 
Sw 	
WFinal ' 	Winitial
Winitial
	 100 
Scanning electron microscopy (SEM)  
Scanning electron microscopy was carried out to study the 
morphological characteristics of ciprofloxacin microspheres. The 
dried microspheres were coated with gold (100 A °) under an argon 
atmosphere in a gold coating unit and Scanning electron 
micrographs were observed [13]. 
In vitro drug release study 
USP–II type dissolution apparatus (paddle type) was performed at 
50 rpm in 900 ml 0.1N HCL. 5 ml of sample was withdrawn at a 
predetermined interval, and the volume of dissolution medium was 
maintained by adding the same volume of dissolution medium to 
maintain the sink condition. The absorption of withdrawn sample 
was measured spectrophotometrically with suitable dilution and the 
corresponding concentration was determined from the respective 
calibration curve. The temperature was maintained at 37 °C 
throughout the studies [14, 15].  
In vitro drug release kinetics 
Kinetic models are best-known tools to describe the drug release pattern 
from immediate and modified release dosage forms. In order to 
investigate the kinetics and mechanism of drug release from prepared 
microspheres of different drug and polymers ratios, the release data 
were examined using Zero order kinetic, First order kinetic, Higuchi 
kinetic, Hixon-Crowell and Korsmeyer-Peppas model [16]. 
RESULTS AND DISCUSSION 
Floating microspheres of ciprofloxacin were prepared using polymers 
such as ethyl cellulose and hydroxypropyl methyl cellulose either alone 
or in combination in various drug and polymer ratios as given in 
formulation composition of microspheres (table 1, 2 and 3) with the help 
of non-aqueous solvent evaporation technique. Formulations FM1 to 
FM4 were prepared using gradually increasing the concentration of 
ethyl cellulose and formulations FM5 to FM8 were prepared using HPMC 
with fixed drug concentration of 100 mg. For the formulations of FM9 to 
FM12 combination strategy of polymers such as ethyl cellulose and 
hydroxypropyl methylcellulose (HPMC) was used. In these formulations, 
the amount of drug was kept constant with varying amount of both the 
polymers with respect to each other.  
All the microspheres obtained from non-aqueous solvent evaporation 
technique were discrete and spherical in shape. The optical microscopic 
data of each formulation is given in table 4. Scanning electron 
microscopy (SEM, fig. 2) was done to determine the surface microscopy 
and internal texture of microspheres. The size of all the microspheres 
was found to be in the range 100-200 µm and increases with the 
increase in polymer concentration. Surface topology report (fig. 2) 
confirms the particle size and provides evidence about the smooth 
surface of prepared microsphere with no fracture.  
 
Fig. 1: Microscopic view of formulation FM9 
 
 
Fig. 2: Scanning electron photomicrograph of formulation FM9
Durgapal et al. 
Int J App Pharm, Vol 9, Issue 1, 2017, 1-8 
 
4 
Table 4: Particle size analysis of microspheres 
Batch code Particle size(µm) mean±SD (n=3) Batch code Particle size(µm) mean±SD (n=3) 
FM1 135.5±2.33 FM2 158.2±2.31 
FM3 175.3±2.71 FM4 198.7±1.29 
FM5 145.5±2.92 FM6 160.7±1.43 
FM7 175.9±1.49  FM8 195.7±2.12 
FM9 120.5±3.56 FM10 145.1±3.52 
FM11 175.7±2.17 FM12 148.7±3.81 
 
Percentage yield of all the formulations (table 5) prepared from non-
aqueous solvent evaporation technique was found in the range 66-85% 
which is sufficiently high. As experimental result revealed % yield value 
was directly related with polymeric concentration. In most of the cases 
as the polymer concentration increase, % yield was also increased. 
The success of floating type of gastro retentive systems depends 
greatly on the parameters such as duration of floating and 
percentage of floating capacity, because as long as the microspheres 
remain buoyant on the surface of gastric fluid they will be capable 
enough to accomplish the criteria of an ideal floating drug delivery 
system which along with the maintenance of buoyancy for 
prolonged period of time allows the slow release of the drug from 
the dosage form which will be absorbed by the upper part of 
gastrointestinal tract which is the absorption site of drug. The 
duration of floating increases when low bulk density polymers were 
used. Parameters such as duration of floating and percentage 
floating capacity of various formulations can be seen from data given 
in table 5. Observed floating duration time was more than 15 h for 
all the prepared formulations. Experimental results clearly revealed 
that the floating duration time and % floating capacity was directly 
related with the amount of polymers used. It may be due to the fact 
that after initial floating, it was the amount of swellable polymer that 
swelled and kept the density<1 which helped in providing buoyancy 
for longer periods of time.  
Drug content of all the formulations except few was found to be 
sufficiently high. From the result of drug entrapment efficiency 
(table 5) it was found that all the prepared formulation entrapped 
more than 90% of drug (except FM7). It was observed that polymer 
concentration did not decide the fate of drug entrapment. 
Optimisation of critical parameters such as mixing time, mixing 
speed at preformulation level plays a major role behind drug 
content and % drug entrapment. 
 
Table 5: Percentage Yield, drug content, drug entrapment and floating parameters of microsphere formulations FM1 to FM12 
Batch 
code 
Evaluation parameters mean±SD (n=3) 
Yield (%) Theoretical drug content 
(mg) 
Practical drug content 
(mg) 
Drug entrapment 
(%) 
Floating duration 
(h) 
% floating 
capacity 
FM1 80±2.43 41.66±1.66 40.8±0.55 97.92±0.13 17±1.6 82±2 
FM2 72.5±1.78 34.51±0.98 33.1±0.91 95.9±0.32 15±1.1 80±2 
FM3 70±3.59 28.57±0.87 27.77±0.76 97.19±0.51 16±1.8 85±3 
FM4 66±2.19 25±1.03 23.12±0.87 92.48±0.40 15±2.1 87±4 
FM5 82.85±2.67 34.48±1.91 32.1±0.79 93.09±0.38 15±2.3 85±2 
FM6 66.66±3.13 33.35±1.77 33.02±0.35 99±0.29 17±1.3 77±3 
FM7 76.66±1.03 43.47±1.61 36.52±0.56 83.99±0.41 19±0.7 86±2 
FM8 72.5±1.45 34.48±0.56 33.6±0.41 97.44±0.39 20±0.3 85±1 
FM9 85.23±2.09 26.34±1.39 25.98±0.32 98.63±0.32 22±0.3 90±2 
FM10 73.33±2.17 45.45±2.01 43.22±0.82 95.09±0.33 18±1.2 82±2 
FM11 72.5±3.41 34.48±1.61 31.72±0.53 91.99±0.52 18±1.5 85±4 
FM12 75±2.77 33.33±2.05 32.92±0.40 98.76±0.18 17±1.2 88±3 
 
All the formulated microspheres shows good flow properties (table 
6) with a value of the angle of repose between 21-29ᵒ.  
The bulk density and the tapped density of all the formulations were 
within short range, i.e. 0.331 gm/cm3 to 0.572 gm/cm3 and 0.348 
gm/cm3 to 0.667 gm/cm3 respectively.  
Carr’s index of all the formulations was found to be less than 15 percent 
which indicates good flow properties. Also, Hausner’s ratios of most of 
the formulations were found to be less than 1.25 which indicates better 
flow properties. Excellent flow properties of prepared floating 
microsphere suggested less polydispersity, complete drying and particle 
size uniformity. 
  
Table 6: Rheological characteristics of microsphere formulations FM1 to FM12 
Batch 
code 
Evaluation of rheological properties mean±SD (n=3) 
Angle of repose (°) Bulk density 
(g/cm3) 
Tapped density 
(g/cm3) 
Carr’s index 
 
Hausner’s ratio 
FM1 24.33±0.05 0.444±0.01 0.487±0.02 8.829±0.67 1.096±0.56 
FM2 21.32±0.03 0.408±0.01 0.465±0.03 12.25±0.58 1.139±0.34 
FM3 27.54±0.05 0.416±0.02 0.487±0.01 14.57±0.43 1.170±0.51 
FM4 24.32±0.1 0.350±0.01 0.390±0.01 10.25±0.19 1.114±0.13 
FM5 29.73±0.02 0.400±0.01 0.465±0.01 13.97±0.13 1.162±0.09 
FM6 26.46±0.09 0.331±0.01 0.348±0.01 4.060±0.14 1.042±0.14 
FM7 25.29±0.09 0.400±0.02 0.444±0.02 9.909±0.21 1.110±0.11 
FM8 27.89±0.07 0.400±0.02 0.425±0.02 5.882±0.25 1.062±0.14 
FM9 29.54±0.05 0.572±0.02 0.667±0.01 14.26±0.19 1.166±0.21 
FM10 24.82±0.05 0.416±0.01 0.487±0.01 14.57±0.22 1.170±0.27 
FM11 25.04±0.05 0.425±0.01 0.487±0.01 12.73±0.28 1.145±0.19 
FM12 21.05±0.05 0.454±00.01 0.512±0.01 11.32±0.11 1.127±0.15 
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Loose surface crystal studies were done to know the excess of drug 
present on the surface of microspheres. These studies play an 
important role in the determination of drug release profile because 
sometimes due to the adherence of crystals of the drug on the surface 
of microspheres they give a false alarm of burst effect which interferes 
in the correct determination of release profile of drug from the dosage 
form. Data given in the table number 7 clearly indicates that there is 
little or no adherence of drug on the surface of microspheres. Less 
surface entrapment signified a large amount of drug was entrapped 
inside the polymeric matrix. It may also conclude from the observed 
result that less surface drug entrapment reduced the chances of burst 
release which provided more controlled release of the drug. 
  
Table 7: Loose surface crystal studies of formulations FM1 to FM12 
Batch Code Loose surface crystal study mean±SD (n=3) 
Drug content in filtrate Loaded dug content(mg) % Total drug content 
FM1 1.519 41.66 3.646±0.69 
FM2 1.213 34.51 3.514±0.91 
FM3 1.131 28.57 3.958±0.73 
FM4 0.862 25 3.448±0.94 
FM5 2.912 34.48 8.445±0.09 
FM6 1.537 33.35 4.608±0.18 
FM7 1.321 43.478 3.038±0.34 
FM8 1.269 34.48 3.680±0.51 
FM9 0.431 26.34 1.598±0.69 
FM10 1.152 45.45 2.534±0.71 
FM11 0.902 34.48 2.616±0.39 
FM12 0.792 33.33 2.372±0.56 
 
One of the important characteristic to know the release of drug 
from the dosage form is the swelling behaviour. As greater the 
swelling greater will be the release of drug from the 
microspheres. Formulations prepared with ethyl cellulose 
showed no significant increase in swelling behaviour as a 
number of polymer increases which can be seen from the data 
given in table number 8. All the formulations showed about 14 to 
15 percent increase in swelling for three hours. Formulations of 
HPMC showed about 14 to 18 percent of swelling for same time 
period, and formulations of ethyl cellulose and HPMC showed 
about17 to 25 percent of swelling for same time period. % 
Swelling was depends on the water uptake characteristics of the 
polymer as well as their polymeric chain relaxation capability. 
Thus the observed values were different from each other. 
  
Table 8: Swelling index of formulations FM1 to FM12 
 Batch code Initial weight (mg) Final weight (mg) Mean % swelling of microspheres±SD (n=3) 
FM1 100 114.5 14.5±1.33 
FM2 100 115.3 15.3±1.29 
FM3 100 115.8 15.8±1.11 
FM4 100 114.7 14.7±1.21 
FM5 100 115.3 15.3±1.49 
FM6 100 114.9 14.9±1.51 
FM7 100 118.8 18.8±1.80 
FM8 100 118.1 18.1±1.72 
FM9 100 117.2 17.2±1.23 
FM10 100 125.8 25.8±1.41 
FM11 100 125.5 25.5±1.32 
FM12 100 125.3 25.3±1.88 
 
In vitro release of ciprofloxacin from different formulations were 
studied in 0.1N HCl for 10 h using USP-II type dissolution apparatus. 
From the release data of different formulations it has been observed 
that the cumulative percentage release of drug from the 
microspheres depends upon the type and amount of polymer used. 
The release data of dosage form given in the table number 9 and 10 
revealed the fact that the combination of polymers also affects the 
release rate. For the formulation FM1 to FM4 ethyl cellulose was used 
in gradually increasing concentrations with constant drug 
concentration. Important characteristics of ethylcellulose such as its 
non-toxicity, non-allergic and nonirritant behaviour make this 
polymer one of the best for the formulation of microspheres. From 
the present study, it was observed that the formulations prepared 
from this polymer possess lower densities (having a hollow core), 
exhibit higher buoyancy and are expected to be retained in the 
gastric environment for a prolonged period of time. Most of the 
formulations prepared from ethyl cellulose did not show any burst 
effect or lag time which indicates homogeneous drug distribution. 
The release of ciprofloxacin significantly decreased with increasing 
amount of ethyl cellulose because when the higher concentration of 
polymer has used the density of polymer matrix gets increased due 
to the formation of the strong polymeric network which increases 
the diffusional path length. Thus the drug release from the polymer 
matrix gets reduced. HPMC was selected for the preparation of 
formulations FM5 to FM8 because it is known to be soluble at pH>5.5 
and has low solubility in acidic medium. These characteristics of 
HPMC help the dosage form to control the release rate of a 
medicament for desired period of time so that it can meet the 
criteria of ideal floating dosage form. Also, more than 90% of 
microspheres prepared from HPMC maintained the floating duration 
for 15 to 24 h of a longer period of time and those microspheres 
which lost their buoyancy might successfully pass through the 
stomach and release the drug in significant amount in the upper part 
of gastrointestinal tract the absorption site of the drug. 
Formulations FM9 to FM12 were prepared using ethyl cellulose and 
hydroxypropyl methylcellulose (HPMC). Formulation FM9 shows 
29.56% of cumulative drug release at first hour and FM11 shows 
16.403% of cumulative drug release at first hour. The rate of FF11 
formulation is very much controlled because of the combination of 
polymers. When both the polymers are combined, they form a polymeric 
matrix of high density due to the formation of the strong polymeric 
network. When the concentration of ethylcellulose is increased as in FF11 
(drug: ethylcellulose: HPMC 1:2:1) compared to FM9 (drug: ethyl-
Durgapal et al. 
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cellulose: HPMC 1:1:1) the cumulative release of ciprofloxacin 
significantly decreased because increase in concentration of 
ethylcellulose increases the density of polymer matrix which in turns 
increases the diffusional path length. The release of FM9 and FM10 is 
higher than that of FM11 because at lower polymer concentration smaller 
microspheres are formed; due to the small size of microspheres larger 
surface area is exposed to dissolution medium giving rise to faster drug 
release. Formulation FM12 (drug: ethylcellulose: HPMC 2:1:1) shows 
51.48% drug release at first hour due to improper drug and polymer 
ratio. 
  
Table 9: In vitro drug release profile of formulations FM1 to FM6 
Time (h) % cumulative amount of drug release (n=3) mean±SD  
FM1 FM2 FM3 FM4 FM5 FM6 
0 0 0 0 0  0 0 
1 34.41±1.18 32.084±1.38 26.93±1.06 20.242±0.93 28.59±1.24 27.256±0.95 
2 40.77±1.23 43.138±1.51 29.686±1.32 23.468±1.97 36.439±0.99 32.647±0.55 
3 38.35±1.45 40.114±1.90 32.456±1.48 27.491±1.35 36.61±1.89 39.051±1.36 
4 42.98±0.13 41.422±1.29 39.584±1.27 33.092±0.89 45.01±1.23 49.321±1.27 
5 43.21±1.00 42.193±1.62 43.277±1.91 33.274±0.94 45.89±0.57 54.561±0.96 
6 43.89±1.23 38.616±1.83 47.857±1.32 35.012±1.37 46.844±1.41 59.342±1.54 
7 43.24±1.14 38.824±1.22 48.986±1.25 40.653±1.59 52.728±1.07 64.842±0.85 
8 43.48±1.62 42.296±1.76 52.726±1.53 47.102±1.28 58.72±1.12 67.594±0.49 
9 45.29±0.99 43.715±1.54 58.223±1.87 51.25±0.79 68.059±0.38 69.067±1.33 
10 47.36±0.82 45.039±1.39 60.926±1.31 54.641±0.81 72.700±0.75 72.491±0.59 
 
Table 10: In vitro drug release profile of formulations FM7 to FM12 
Time (h) % cumulative amount of drug release (n=3) mean±SD 
FM7 FM8 FM9 FM10 FM11 FM12 
0 0 0 0 0 0 0 
1 49.82±1.12 12.631±0.76 29.56±0.49 34.615±1.93 16.403±0.63 51.48±1.94 
2 68.84±1.83 14.807±0.98 30.15±0.81 34.807±1.99 17.588±0.87 58.12±1.89 
3 69.78±0.97 15.084±1.71 35.73±0.94 35.000±1.78 19.325±0.59 58.44±1.49 
4 72.29±0.27 17.982±1.27 36.76±1.13 36.327±1.26 22.165±0.92 59.43±1.62 
5 73.22±1.37 18.573±1.03 37.37±0.73 41.633±1.06 22.834±1.34 60.99±1.39 
6 74.157±1.93 20.259±1.47 40.49±0.28 41.86±0.63 27.332±1.95 61.33±1.93 
7 74.559±1.80 26.342±0.91 43.41±1.03 45.491±0.71 29.668±1.27 62.93±1.28 
8 72.28±0.75 32.801±0.77 44.28±0.32 44.602±1.83 31.47±0.25 69.62±1.11 
9 76.41±0.69 34.637±1.87 49.51±0.27 52.559±1.44 34.921±0.58 70.00±1.51 
10 74.6±1.91 53.938±1.29 60.13±0.92 55.34±1.01 36.749±0.22 73.55±1.79 
 
 
Fig. 3: In vitro dissolution plots of formulation FM1-FM4 
 
 
Fig. 4: In vitro dissolution plots of formulation FM5-FM8 
 
Fig. 5: In vitro dissolution plots of formulation FM9-FM12 
 
In order to establish the mechanism of release of the drug from the 
immediate and modified release, dosages forms kinetic models are 
used. The drug release data were subjected to various mathematical 
kinetic models like zero order, first order, etc. The data were also 
subjected to Higuchi’s model and Korsmeyer model. Korsmeyer 
model is widely used; when the release mechanism is not well 
known or when more than one type of release phenomena could be 
involved. Korsmeyer and Peppas equation: Mt/M∝ = Ktn, where 
Mt/M∝ is the fractional drug release in time‘t’. K= constant 
incorporating of structural and geometric characteristics of the 
controlled release device, n = diffusional release exponent indicative 
of release mechanism. The ‘n’ value could be used to characterize 
different release mechanisms as follows n = 0.5 means Fickian 
diffusion, 0.5<n<1.0 non-Fickian diffusion, and n = 1.0 Case II 
diffusion [14]. The interpretation of data was based on the value of 
the resulting regression coefficients. 
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For all the formulations the values of R2of zero order, first order and 
Higuchi were given in table number 11 and from this table it was 
clearly observed that for most of the formulations the value of 
resulting regression coefficient (R2) is highest for Higuchi model 
which shows all the formulations predominantly followed Higuchi 
square root kinetics indicating a diffusion dependent release as 
expected from a matrix system like the microspheres. The 
corresponding n values of the maximum formulation were below 
0.45 which indicates that the formulations released the drug 
through Fickian diffusion mechanism. 
  
Table 11: Result of regression coefficients of release data by curve fitting method on zero-order, first-order and Higuchi kinetic model 
and their diffusion exponent (n)* 
Batch code regression coefficients (r2) n* 
Zero-order First-order Higuchi 
FM1 0.705 0.448 0.952 0.114 
FM2 0.621 0.620 0.915 0.09 
FM3 0.934 0.953 0.973 0.435 
FM4 0.930 0.951 0.983 0.376 
FM5 0.797 0.862 0.916 0.218 
FM6 0.652 0.698 0.938 0.074 
FM7 0.719 0.636 0.724 0.150 
FM8 0.972 0.820 0.971 0.581 
FM9 0.811 0.840 0.917 0.269 
FM10 0.762 0.813 0.908 0.202 
FM11 0.918 0.927 0.970 0.372 
FM12 0.697 0.778 0.928 0.134 
* Mt/M∞ = kt n 
 
On the basis of all the evaluation parameters formulations FM9 
was selected as final formulations, and its statistical evaluation 
was done using analysis of variance (ANOVA) at P≤0.05 
significance level and it was found to be statistically significant 
with P value<0.05.  
The compatibility study was performed by means of FTIR 
instrument. The result was based on matching the main peak of the 
pure drug with the formulation, as the peak table (table number 12) 
shows there was no interaction between ciprofloxacin 
hydrochloride and polymer. 
 
 
Fig. 6: FTIR spectra of ciprofloxacin hydrochloride 
 
 
Fig. 7: FTIR spectra of FM9 formulation 
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Table 12: FTIR peak table 
Drug peak Formulation peak Peak characteristics 
3288.21 3285.20 -OH stretch 
1710.6 1707.60 -COOH stretch 
1627.01 1627.00 -C==O vibration 
1498.84 1496.50 C-H stretch 
1384.81 1381.13 Aromatic C=C 
1272.64 1271.20 C-F stretch 
 
CONCLUSION 
Floating micro-particles of ciprofloxacin were successfully developed 
using polymers such as ethyl cellulose and HPMC. Results obtained 
shows that ciprofloxacin floating microspheres increases the gastric 
residence time as well as bioavailability and simultaneously decrease 
the dosing interval and dosing amount. It can be concluded that the 
developed floating microspheres of ciprofloxacin can be used for 
prolonged drug release in the stomach for at least 8 h, thereby 
improving the bioavailability and patient compliance.  
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